α-淀粉酶与炎症反应在呼吸机相关性肺炎患者中的交互作用及其预后价值
该前瞻性队列研究纳入河北医科大学第二医院ICU 2020年6月至2023年6月机械通气患者100例(VAP组60例、非VAP组40例),另设健康对照100例,随访28天。VAP组血清α-AMS、IL-6、TNF-α、CRP显著高于非VAP组和健康对照组,且随APACHE II分级的轻、中、重度递增而升高。α-AMS与IL-6、TNF-α、CRP及APACHE II评分正相关(r值0.404、0.392、0.493、0.493,均P<0.01)。多因素Logistic回归显示α-AMS(OR=1.428,95%CI 1.098-1.856)等为28天预后独立影响因素;α-AMS预测不良预后最佳截断值敏感度81.3%、特异度75.0%、AUC 0.791,联合参数AUC 0.868(95%CI 0.798-0.938)。
要点
- VAP组60例血清α-AMS、IL-6、TNF-α、CRP显著高于非VAP组40例及健康对照100例,非VAP组又高于健康对照组。
- VAP患者按APACHE II分层:轻度24例、中度20例、重度16例,α-AMS及炎症指标在重度组显著高于中度组和轻度组,中度组显著高于轻度组。
- α-AMS与IL-6、TNF-α、CRP、APACHE II评分正相关(r=0.404、0.392、0.493、0.493,均P<0.01)。
- α-AMS预测VAP 28天不良预后的最佳截断值敏感度81.3%、特异度75.0%、AUC 0.791,显著高于IL-6、TNF-α、CRP(P<0.05)。
- 联合参数预测性能最佳,AUC 0.868(95%CI 0.798-0.938)、敏感度87.5%、特异度79.5%,显著优于各单项指标(P<0.05)。
适用人群与场景
- 河北医科大学第二医院ICU 2020年6月至2023年6月收治的机械通气患者100例,按是否发生VAP分为VAP组60例与非VAP组40例。
- VAP患者按APACHE II分层:轻度(APACHE II<10分)24例、中度(APACHE II 10-20分)20例、重度(APACHE II>20分)16例。
- 同期在本院健康体检的健康者100例作为健康对照组。
诊断标准与关键阈值
- VAP诊断依据是否发生VAP进行分组,原文未列出具体诊断标准条目。
- 病情严重程度按APACHE II评分分层:轻度<10分、中度10-20分、重度>20分。
研究设计与关键结果
- 研究类型为前瞻性队列研究,纳入机械通气患者100例(VAP组60例、非VAP组40例)及健康对照100例,随访28天;VAP组28天存活44例、死亡16例。
- VAP组血清α-AMS、IL-6、TNF-α、CRP显著高于非VAP组和健康对照组,非VAP组上述指标显著高于健康对照组。
- VAP不同严重程度组间α-AMS、IL-6、TNF-α、CRP及APACHE II评分差异有统计学意义,重度组显著高于中度组和轻度组,中度组显著高于轻度组。
- Pearson相关分析:α-AMS与IL-6(r=0.404)、TNF-α(r=0.392)、CRP(r=0.493)、APACHE II评分(r=0.493)正相关,均P<0.01。
- 多因素Logistic回归显示年龄(OR=1.340,95%CI 1.119-1.605)、气管切开(OR=3.050,95%CI 1.016-9.157)、糖尿病(OR=1.379,95%CI 1.102-1.724)、通气时间≥7天(OR=2.557,95%CI 1.163-5.623)、α-AMS(OR=1.428,95%CI 1.098-1.856)、IL-6(OR=1.543,95%CI 1.005-2.371)、TNF-α(OR=2.228,95%CI 1.107-4.485)、CRP(OR=1.252,95%CI 1.131-1.387)、APACHE II评分(OR=1.422,95%CI 1.033-1.957)为VAP 28天预后独立影响因素(均P<0.05)。
- ROC曲线:α-AMS预测VAP不良预后最佳截断值敏感度81.3%、特异度75.0%、AUC 0.791,显著高于IL-6、TNF-α、CRP(P<0.05);联合参数AUC 0.868(95%CI 0.798-0.938)、敏感度87.5%、特异度79.5%,显著优于各单项指标(P<0.05)。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为VAP可导致外周血α-AMS及炎症因子水平升高,α-AMS与炎症标志物在重度VAP患者中存在交互作用。
- 作者认为上述标志物与病情严重程度和预后密切相关,对预测患者结局有重要意义。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the interaction between α-amylase (α-AMS) and inflammatory response in patients with ventilator-associated pneumonia (VAP) and their predictive value for prognosis.
METHODS: A prospective cohort study was conducted. Patients with mechanical ventilation who were treated in the intensive care unit (ICU) of the Second Hospital of Hebei Medical University from June 2020 to June 2023 were enrolled, and the patients were divided into VAP group and non-VAP group according to whether VAP occurred. VAP patients were stratified into mild [acute physiology and chronic health evaluation II (APACHE II) < 10 scores], moderate (APACHE II were 10-20 scores), and severe (APACHE II > 20 scores) groups based on the APACHE II. All patients were followed up for 28 days. In addition, healthy subjects who underwent health examination in our hospital at the same time were selected as the healthy control group. Baseline data including gender, age, mechanical ventilation mode, mechanical ventilation time, underlying diseases, drug use, and laboratory test indicators were collected. The serum levels of α-AMS, interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), C-reactive protein (CRP) and other inflammatory factors were analyzed and compared. Pearson correlation analysis was performed to analyze the correlation between serum α-AMS and inflammatory factors. Logistic regression was used to analyze the influencing factors of poor prognosis in patients with VAP. The receiver operator characteristic curve (ROC curve) was plotted to evaluate the predictive value of α-AMS on the poor prognosis of patients with VAP.
RESULTS: A total of 100 mechanically ventilated patients were enrolled, including 60 cases in the VAP group and 40 cases in the non-VAP group. Among the patients with VAP, there were 24 cases in the mild group, 20 cases in the moderate group, and 16 cases in the severe group. A total of 44 patients survived at 28 days, while 16 died. Additionally, 100 healthy individuals were included as the healthy control group. Serum levels of α-AMS, IL-6, TNF-α and CRP in the VAP group were significantly higher than those in the non-VAP group and the healthy control group, while the levels of α-AMS, IL-6, TNF-α and CRP in the non-VAP group were significantly higher than those in the healthy control group. There were statistically significant differences in serum α-AMS, IL-6, TNF-α, CRP levels and APACHE II scores among VAP patients with different disease severities, and the levels of the above indicators in the severe group were significantly higher than those in the moderate group and mild group, and the levels of the above indicators in the moderate VAP group were significantly higher than those in the mild group. Pearson correlation analysis showed that serum α-AMS was positively correlated with IL-6, TNF-α, CRP, and APACHE II scores (r values were 0.404, 0.392 and 0.493, 0.493, all P < 0.01). Univariate analysis showed that age, mechanical ventilation, diabetes mellitus, ventilation time, ventilation position, prophylactic use of antimicrobial drugs, and serum α-AMS, IL-6, TNF-α, CRP, and APACHE II scores were correlated with the prognosis of VAP patients (all P < 0.05). Multivariate Logistic regression analysis identified age [odds ratio (OR) = 1.340, 95% confidence interval (95%CI) was 1.119-1.605], tracheostomy (OR = 3.050, 95%CI was 1.016-9.157), diabetes mellitus (OR = 1.379, 95%CI was 1.102-1.724), and ventilation time ≥ 7 days (OR = 2.557, 95%CI was 1.163-5.623) and serum α-AMS (OR = 1.428, 95%CI was 1.098-1.856), IL-6 (OR = 1.543, 95%CI was 1.005-2.371), TNF-α (OR = 2.228, 95%CI was 1.107-4.485), CRP (OR = 1.252, 95%CI was 1.131-1.387), APACHE II scores (OR = 1.422, 95%CI was 1.033-1.957) were independent influencing factors for the 28-day prognosis of patients with VAP (all P < 0.05). ROC curve analysis demonstrated that serum α-AMS, IL-6, TNF-α and CRP exhibited significant predictive performance on the prognosis of patients with VAP. The best cut-off value for α-AMS had a sensitivity of 81.3%, specificity of 75.0%, and an area under the ROC curve (AUC) of 0.791, which was significantly higher than those of inflammatory markers IL-6, TNF-α, and CRP (P < 0.05). The combined parameter diagnostic performance was significantly better than those of individual parameters (P < 0.05), with the highest diagnostic performance when combined, corresponding to an AUC of 0.868 (95%CI was 0.798-0.938), sensitivity of 87.5%, and specificity of 79.5%.
CONCLUSIONS: VAP in mechanically ventilated patients can lead to an increase in the levels of peripheral blood α-AMS and inflammatory factors, and there is an interaction between α-AMS and inflammatory markers in severe VAP patients. These markers are closely related to the severity of the disease and prognosis and have significant implications for predicting patient outcomes.
参考来源
- Liu Y, Peng Y, Hu Y, et al. [Interaction of α-amylase and inflammatory response in patients with ventilator-associated pneumonia and their prognostic value]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 40820528. doi:10.3760/cma.j.cn121430-20240409-00321
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。